Psychedelic Research Group

Psychedelic Research Group

Menu

  • Home
  • Our Research
  • News Articles
  • Blog
  • Article Grid
  • Videos

trial

Psychedelics pioneer keeps his inner hippy in check

Psychedelics pioneer keeps his inner hippy in check

Psychedelics pioneer keeps his inner hippy in check   After giving people LSD and psilocybin, Robin Carhart-Harris is convinced of psychedelic therapy’s potential – but he daren’t get too excited about it .entry-header “I have conviction in psychedelics as tools

Author on Source September 8, 2017September 8, 2017 News Articles Read more

Focus

The Psychedelic Research Group at Imperial focuses on two main research areas:
  1.  The action of psychedelic drugs in the brain.
  2. Their clinical utility, e.g. as aides to psychotherapy, with a particular focus on depression.
The group is lead by Dr Robin Carhart-Harris.

Search

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Blog
News Articles
Published Articles

Twitter

Psychedelic Research Group
2 hours ago
Imperial PRG's Twitter avatar
Imperial PRG
@Imperial_PRG

Watch “Psychedelic Ceremony Study” on #Vimeo t.co/AMRy21cTDC

  • Reply
  • Retweet 0
  • Like 1
6 hours ago
Chris Timmermann's Twitter avatar
Chris Timmermann
@neurodelia

I will be speaking at New Scientis Live, this September. Come along to get the latest on our DMT research. #NSLive t.co/an4AY7A9CQ

Retweeted by Imperial PRG
  • Reply
  • Retweet 4
  • Like 11
7 hours ago
Beckley Foundation's Twitter avatar
Beckley Foundation
@BeckleyResearch

April 19th is Bicycle Day - when Albert Hofmann became the first person to experience the psychedelic properties of… t.co/M4DhWnuioA

Retweeted by Imperial PRG
  • Reply
  • Retweet 9
  • Like 28
23 hours ago
Imperial PRG's Twitter avatar
Imperial PRG
@Imperial_PRG

@DrArthurBlair And #9/20? @920Coalition

  • Reply
  • Retweet 0
  • Like 0
1 day ago
Imperial PRG's Twitter avatar
Imperial PRG
@Imperial_PRG

Please do share this tweet about our new surveys on general (t.co/hF4o4ZJ02v) and ceremonial use (… t.co/7TIrRG9U02

  • Reply
  • Retweet 31
  • Like 23

F1000 Prime Recommendation

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression

Roseman, L., Nutt D.J., Carhart-Harris R.


Access the recommendation on F1000Prime.

Our Papers


  • Relative Harms and Benefits of DrugsRelative Harms and Benefits of Drugs
  • Finding the Self by Losing the SelfFinding the Self by Losing the Self
  • LSD enhances the emotional response to musicLSD enhances the emotional response to music
  • User perceptions of the benefits and harms of  hallucinogenic drug useUser perceptions of the benefits and harms of hallucinogenic drug use
  • Psychedelic drugs should be legally reclassifiedPsychedelic drugs should be legally reclassified

News Articles about us


  • Depressed? Your doctor might soon prescribe ketamine
  • LSD’s impact on the brain revealed in groundbreaking imagesLSD’s impact on the brain revealed in groundbreaking images
  • Psychoactive substances ban will ‘end brain research’ in Britain, experts warnPsychoactive substances ban will ‘end brain research’ in Britain, experts warn
  • Psychedelic expert: Shrooms will be approved for depression in 10 yearsPsychedelic expert: Shrooms will be approved for depression in 10 years
  • David Nutt – The Psychedelic CrusaderDavid Nutt – The Psychedelic Crusader

Contact Us

Any questions, please feel free to contact us.

Archives

Tags

Psychedelic experienceLysergic acid diethylamideJames RuckerJames J H RuckerCulturePost-traumatic stress disorderSleepThe ObserverMusicmagnetic resonance imagingpersistent homologydrug harmsAlcoholresting statefunctional connectivitymagic mushroomREM sleep5-HT2A receptorBeckley FoundationpsychosisResearch fundingEcstasyPsychologyMain section5-HTMedical researchbrainpsychoactivebrain functional networksMedicineRobin Carhart-HarrisMental healthThe GuardianUK newspsychotherapyFeaturesPoliticsHealthconsciousnessHallucinogensresearchDrugs policyfMRIdefault mode networkNewsDavid NuttSocietyPsychedelicsMDMAPsychedelic therapyserotoninneuroscienceArticleSciencelsdvia bookmarkletDrugsDepressionpsychedelicpsilocybin
Copyright © 2018 Psychedelic Research Group. Powered by WordPress. Theme: Spacious by ThemeGrill.